Stock 8SJ SHANGHAI JUNSHI BIOSCIENCES CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Insiders Shanghai Junshi Biosciences Co., Ltd. Deutsche Boerse AG

Equities

8SJ

CNE100003FF7

Delayed Deutsche Boerse AG
Other stock markets
 03:59:02 2024-06-27 EDT 		5-day change 1st Jan Change
1.39 EUR +0.72% Intraday chart for Shanghai Junshi Biosciences Co., Ltd. +6.11% -46.54%
06-26 Shanghai Junshi Biosciences Breast Cancer Drug Obtains DRC from NMPA; Shares Jump 8% MT
06-25 Shanghai Junshi Biosciences Co., Ltd. Receives the Drug Registration Certificate Issued by the National Medical Products Administration CI

Insiders

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Shanghai Junshi Biosciences Co., Ltd. Announces Board Changes
CI
Shanghai Junshi Biosciences Co., Ltd. Announces Executive Changes
CI
Shanghai Junshi Biosciences Co., Ltd. Announces Change of Chief Executive Officer
CI
Shanghai Junshi Biosciences Co., Ltd. Announces Change of General Manager
CI
Shanghai Junshi Biosciences Co., Ltd. and Topalliance Biosciences Inc Appoints Li Ning as Vice Chairman of the Third Session of the Board
CI
Shanghai Junshi Biosciences Co., Ltd. Directors Appointments
CI
Shanghai Junshi Biosciences Co., Ltd. Announces Resignation of Feng Hui as Chief Operations Officer and Announces Re-Designation of Feng Hui as Non-Executive Director from His Previous Role as an Executive Director
CI
Shanghai Junshi Biosciences Co., Ltd. Announces Resignation of Wu Hai as Non-Executive Director
CI
Shanghai Junshi Biosciences Co., Ltd. Announces Board Changes
CI
Shanghai Junshi Biosciences Co., Ltd. Announces Board Changes
CI
Shanghai Junshi Biosciences Co., Ltd. Appoints Zou Jianjun as Executive Director
CI
Shanghai Junshi Biosciences Co., Ltd. Appoints Zou Jianjun as Deputy General Manager and Global Research and Development President of the Company with Effect from 20 April 2022
CI
Shanghai Junshi Biosciences Announces Appointment of Independent Non-Executive Director and Change in Composition of the Nomination Committee And the Remuneration and Appraisal Committee
CI
Junshi Biosciences Names Director as Co-CEO
MT
Shanghai Junshi Biosciences Co., Ltd. Announces Executive Changes
CI
Alphamab Oncology Hires Former Junshi Bio Marketing Head as Commercial Chief; Shares Jump 3%
MT
Shanghai Junshi Biosciences Co., Ltd. Announces Resignation of Jiang Hualiang as an Independent Non-Executive Director, Chairman of the Nomination Committee and Member of the Remuneration and Appraisal Committee
CI
Junshi Biosciences Appoints Wei Qian as Chief Commercial Officer
CI
Shanghai Junshi Biosciences Co., Ltd Announces Executive Changes
CI
Shanghai Junshi Biosciences Co., Ltd. Announces Management Changes
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. 1877 Stock
  4. 8SJ Stock
  5. News Shanghai Junshi Biosciences Co., Ltd.
  6. Insiders